Date Posted
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has reached its enrollment goal of 108,508 women, as announced today by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). The study, funded by the National Cancer Institute (NCI), one of the National Institutes of Health, will now proceed with the completion of regularly scheduled mammograms and follow-up on all participants through 2027.